Grillo-López, A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2002

Language:

english

File:

PDF, 177 KB

english, 2002

2

The ODAC Chronicles – Part 2. Statistics and clinical medicine in the USA: the triumph of science over art?

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2004

Language:

english

File:

PDF, 290 KB

english, 2004

3

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

McLaughlin, P, Grillo-López, A J, Link, B K, Levy, R, Czuczman, M S, Williams, M E, Heyman, M R, Bence-Bruckler, I, White, C A, Cabanillas, F, Jain, V, Ho, A D, Lister, J, Wey, K, Shen, D, Dallaire, B

Journal:

Journal of Clinical Oncology

Year:

1998

Language:

english

File:

PDF, 731 KB

english, 1998

4

Disseminated M. kansasii infection in a patient with chronic granulocytic leukemia

Antonio J. Grillo-López, Ezequiel Rivera, María Castillo-Staab, Norman Maldonado

Journal:

Year:

1971

Language:

english

File:

PDF, 827 KB

english, 1971

5

148 90Y-anti-CD20 monoclonal antibody therapy for recurrent B cell lymphoma

Susan J. Knox, Michael L. Goris, Kirk D. Trisler, Tom A. Davis, Tina-Marie Liles, Sherry F. Fowler, Paul C. Chinn, Ron A. Morena, Brian K. Dallaire, Antonio J. Grillo-López, Nimisha Deb, Mark Becker,

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1995

Language:

english

File:

PDF, 118 KB

english, 1995

6

Direct complement lysis as a major effector mechanism in rituximab (anti-CD20) therapy of B cell lymphomas

A. Harjunpää, T. Wiklund, S. Junnikkala, R. Janes, J. Collan, J. Rosenberg, D. Lee, A. Grillo-Lopez, S. Meri

Journal:

Immunopharmacology

Year:

2000

Language:

english

File:

PDF, 148 KB

english, 2000

7

Zevalin radioimmunotherapy (RIT) for relapsed of refractory B-cell non-Hodgkin's lymphoma (NHL): interim clinical and dosimetry findings support a weight-adjusted dosing schedule

E.M Kornmehl, G.A Wiseman, R.B Sparks, B.R Leigh, W.D Erwin, D.A Silverman, D.A Podoloff, J Welsh, W.L Dunn, L.I Gordon, A.J Grillo-López, C.A White

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2000

Language:

english

File:

PDF, 270 KB

english, 2000

8

Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8

G. Wiseman, T. Witzig, C.A. White, A.J. Grillo-López, L. Gordon, C. Emmanouilides, A. Raubitschek, W. Dunn, P. Chinn, J. Gutheil, N. Janakiraman, R.J. Schilder

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1998

Language:

english

File:

PDF, 122 KB

english, 1998

9

2217 IDEC-Y2B8 (90YTTrium ibritumomab tiuxetan) radioimmunotherapy safety results in relapsed or chemotherapy refractory non-Hodgkin's lymphoma patients treated at reduced doses because of pre-existing thrombocytopenia

G.A. Wiseman, C.A. White, T.E. Witzig, L.I. Gordon, N. Bartlett, R.L. Levy, J.L. Murray, C. Emmanouilides, S. Spies, C. Zhang, A.J. Grillo-López

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

10

Complement activation plays a key role in the side-effects of rituximab treatment

L. E. Van Der Kolk, A. J. Grillo-López, J. W. Baars, C. E. Hack, M. H. J. Van Oers

Journal:

British Journal of Haematology

Year:

2001

Language:

english

File:

PDF, 244 KB

english, 2001

11

Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma

J Maral, M Poisson, BF Pertuiset, P Mashaly, M Weill, CI Jacquillat, AJ Grillo-Lopez

Journal:

Journal of Neuro-Oncology

Year:

1985

Language:

english

File:

PDF, 369 KB

english, 1985

12

A phase I trial of ametantrone acetate (NSC-287513)

Richard A. Gams, Frederick Ostroy, John F. Bender, Antonio J. Grillo-López

Journal:

Investigational New Drugs

Year:

1985

Language:

english

File:

PDF, 444 KB

english, 1985

13

Trimetrexate: a new antifol entering clinical trials

Peter J. O'Dwyer, D. Dale Shoemaker, J. Plowman, J. Cradock, A. Grillo-Lopez, B. Leyland-Jones

Journal:

Investigational New Drugs

Year:

1985

Language:

english

File:

PDF, 374 KB

english, 1985

14

Diaziquone (AZQ)

John F. Bender, Antonio J. Grillo-Lopez, Juan G. Posada

Journal:

Investigational New Drugs

Year:

1983

Language:

english

File:

PDF, 842 KB

english, 1983

15

CI-921: An analog of amsacrine with experimental activity against solid tumors

William R. Grove, Linda W. DeLap, Antonio J. Grillo-López

Journal:

Investigational New Drugs

Year:

1986

Language:

english

File:

PDF, 341 KB

english, 1986

16

Pharmacokinetics of ametantrone acetate (NSC-287513)

John G. Kuhn, Carol E. Balmer, Thomas M. Ludden, David M. Loesch, Daniel D. Hoff, John F. Bender, Antonio J. Grillo-Lopez

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1987

Language:

english

File:

PDF, 1.05 MB

english, 1987

17

Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil

Gary R. Hudes, Frank LaCreta, Robert J. DeLap, Antonio J. Grillo-Lopez, Robert Catalano, Robert L. Comis

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1989

Language:

english

File:

PDF, 618 KB

english, 1989

18

Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck

Susan Urba, James Doroshow, Christine Cripps, Francisco Robert, Enrique Velez-Garcia, Brian Dallaire, David Adams, Randall Carlson, Antonio Grillo-Lopez, John Gyves

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1992

Language:

english

File:

PDF, 260 KB

english, 1992

19

Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole

Karl Bélanger, Jacques Jolivet, Jean Maroun, David Stewart, Antonio Grillo-Lopez, Lloyd Whitfield, Nancy Wainman, Elizabeth Eisenhauer

Journal:

Investigational New Drugs

Year:

1993

Language:

english

File:

PDF, 552 KB

english, 1993

20

Monoclonal Antibody Therapy for B-Cell Lymphoma

Antonio J. Grillo-López

Journal:

International Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 98 KB

english, 2002

21

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

van der Kolk, L E, Grillo-López, A J, Baars, J W, van Oers, M H J

Journal:

Year:

2003

Language:

english

File:

PDF, 132 KB

english, 2003

22

Anti-CD20 monoclonal antibodies as novel treatments for non-Hodgkin's lymphoma

Christine A. White, Anne Larocca, Antonio J. Grillo-López

Journal:

Pharmaceutical Science & Technology Today

Year:

1999

Language:

english

File:

PDF, 1.99 MB

english, 1999

23

90Y-ibritumomab tiuxetan: Rationale for patient selection in the treatment of indolent non-Hodgkin’s lymphoma

Antonio J. Grillo-López

Journal:

Seminars in Oncology

Year:

2005

Language:

english

File:

PDF, 238 KB

english, 2005

24

Introduction to the first International Workshop on Nuclear Oncology

Angelika Bischof-Delaloye, Peter S. Conti, Antonio Grillo-López, Anton Hagenbeek

Journal:

Seminars in Oncology

Year:

2005

Language:

english

File:

PDF, 68 KB

english, 2005

25

Rituximab: Ongoing and future clinical development

Antonio J Grillo-López, Eric Hedrick, Michelle Rashford, Mark Benyunes

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 135 KB

english, 2002

26

Immunotherapy of relapsed B-cell lymphoma with an anti-CD20 antibody (IDEC-C2B8)

A.J. Grillo-López

Journal:

Immunotechnology

Year:

1996

Language:

english

File:

PDF, 271 KB

english, 1996

27

The pharmacokinetics of rituximab following an intravitreal injection

Hyuncheol Kim, Karl G. Csaky, Chi-Chao Chan, Peter M. Bungay, Robert J. Lutz, Robert L. Dedrick, Peng Yuan, Jay Rosenberg, Antonio J. Grillo-Lopez, Wyndham H. Wilson, Michael R. Robinson

Journal:

Experimental Eye Research

Year:

2006

Language:

english

File:

PDF, 193 KB

english, 2006

28

Review of single agent IDEC-C2B8 safety and efficacy results in low-grade or follicular non-Hodgkin's lymphoma (NHL)

C.A. White, A.J. Grillo-López, D. Maloney, D. Bodkin, M. Czuczman, P. McLaughlin, F. Cabanillas, A. Saven, M. Saleh

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 39 KB

english, 1997

29

Antibody-Targeted Immunotherapy for Treatment of Malignancy

White, Christine A., Weaver, Robin L., Grillo-López, Antonio J.

Journal:

Annual Review of Medicine

Year:

2001

Language:

english

File:

PDF, 341 KB

english, 2001

30

The first antibody therapy for cancer: a personal experience

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2013

Language:

english

File:

PDF, 876 KB

english, 2013

31

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Wiseman, Gregory A., Leigh, Bryan R., Erwin, William D., Sparks, Richard B., Podoloff, Donald A., Schilder, Russell J., Bartlett, Nancy L., Spies, Stewart M., Grillo-López, Antonio J., Witzig, Thomas

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

2003

Language:

english

File:

PDF, 374 KB

english, 2003

32

Clinical activity of the monoclonal antibody (MAB) IDEC-C2B8 in patients (pts) with relapsed low-grade or follicular NHL (R-LG/F NHL)

Grillo-López, A.J., White, C.A., Dallaire, B.K., Vams, C., Shen, C.D., Weaver, R.

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 391 KB

english, 1997

33

IDEC-C2B8-induced B cell depletion is not associated with significant immune suppression or infection

White, C.A., Grillo-López, A.J., McLaughlin, P., Maloney, D., Link, B., Levy, R., Cohen, R.

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 269 KB

english, 1997

34

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

Vose, J. M., Link, B. K., Grossbard, M. L., Czuczman, M., Grillo-Lopez, A., Fisher, R. I.

Journal:

Leukemia and Lymphoma

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

35

The USA’s healthcare debacle: the role of the US FDA

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2010

Language:

english

File:

PDF, 160 KB

english, 2010

36

Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab

Czuczman, M. S., Grillo-López, A. J., Alkuzweny, B., Weaver, R., Larocca, A., Mclaughlin, P.

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 292 KB

english, 2006

37

USA’s healthcare reform: why it will not work

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2010

Language:

english

File:

PDF, 598 KB

english, 2010

38

USA’s healthcare reform: challenges and opportunities

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2010

Language:

english

File:

PDF, 143 KB

english, 2010

39

The USA’s healthcare reform: the cost of prescription medicines

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2010

Language:

english

File:

PDF, 612 KB

english, 2010

40

AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2002

Language:

english

File:

PDF, 163 KB

english, 2002

41

Is rituximab effective as a single agent in mantle-cell lymphoma?

Grillo-López, Antonio J

Journal:

Nature Clinical Practice Oncology

Year:

2005

Language:

english

File:

PDF, 72 KB

english, 2005

42

The ODAC Chronicles: Part 7. Tale of two goals

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 41 KB

english, 2005

43

Rituximab (Rituxan®/MabThera®): the first decade (1993–2003)

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

44

Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell Lymphoma

Harjunpää, Antti, Wiklund, Tom, Collan, Juhani, Janes, Rita, Rosenberg, Jay, Lee, Dana, Grillo-López, Antonio, Meri, Seppo

Journal:

Leukemia and Lymphoma

Year:

2001

Language:

english

File:

PDF, 547 KB

english, 2001

45

Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils

van der Kolk, L E, de Haas, M, Grillo-López, A J, Baars, J W, van Oers, M H J

Journal:

Year:

2002

Language:

english

File:

PDF, 227 KB

english, 2002

46

The ODAC chronicles: Part 1. My first ODAC experience

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2004

Language:

english

File:

PDF, 276 KB

english, 2004

47

The ODAC Chronicles: Part 3. The FDA’s philosophy and process for cancer drug evaluation and approval

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 62 KB

english, 2005

48

The ODAC Chronicles: Part 5. Prostate cancer endpoints

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 63 KB

english, 2005

49

The ODAC Chronicles: Part 6b. ODAC’s structure and function

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

50

The ODAC Chronicles: Part 6a. ODAC’s structure and function

Grillo-López, Antonio J

Journal:

Expert Review of Anticancer Therapy

Year:

2005

Language:

english

File:

PDF, 54 KB

english, 2005